Wyeth Projects Prevnar Sales Of 20 Mil. Doses For 2004; Fill/Finish Facility Approved

Batches produced "at risk" at the Cardinal facility will be released in early May, the company said. Wyeth expects to feel the effects of the supply improvements in the third and fourth quarters.